Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer displays site revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error screen, replacing the study record content with a standard error page.SummaryDifference18%

- Check37 days agoChange DetectedRevision: v3.7.0 was added to the page, replacing the previous Revision: v3.6.6. This update reflects a version upgrade and does not alter the study details or other visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, signaling an internal update to the site rather than a change to the study content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor site update rather than a modification to study details or results.SummaryDifference0.0%

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.